Harnessing multi-omics and artificial intelligence: revolutionizing prognosis and treatment in hepatocellular carcinoma

Harnessing multi-omics and artificial intelligence: revolutionizing prognosis and treatment in hepatocellular carcinoma

BackgroundHepatocellular carcinoma (HCC) is the most prevalent form of liver cancer, characterized by elevated mortality rates and heterogeneity. Despite advancements in treatment, the development of personalized therapeutic strategies for HCC remains a substantial challenge due to the intricate mol...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhen Wang, Gangchen Zhou, Rongchuan Cao, Guolin Zhang, Yongxu Zhang, Mingyue Xiao, Longbi Liu, Xuesong Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-07-01
Series:Frontiers in Immunology
Subjects:
hepatocellular carcinoma (HCC)
multi-omics
artificial intelligence-derived risk score (AIDRS)
molecular subtypes
sorafenib
transcatheter arterial chemoembolization (TACE)
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1592259/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2025.1592259/full

Similar Items